Return to site

Vascular Closure Devices Market Growing Technology Opportunities and Future Business Trends to 2022 - Terumo Corporation, Abbott, Cardinal Health Inc., and Cardiva Medical Inc

The global vascular closure devices market is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%.

· Medical Devices,Biotechnology,Healthcare,Pharmaceuticals

Large number of approvals for vascular closure devices, the high prevalence of cardiovascular diseases, high prevalance of obesity, and increasing focus of market players on large-bore vascular closure devices.

The global vascular closure devices market is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%.

Major Key Players of the Vascular Closure Device Market are:

Terumo Corporation (Japan), Abbott (U.S.), Cardinal Health Inc. (U.S.), Cardiva Medical Inc. (U.S.), Morris Innovative, Inc. (U.S.), Medtronic plc (Ireland), Essential Medical, Inc. (U.S.), Merit Medical Systems, Inc. (U.S.), TZ Medical, Inc. (U.S.), and Vasorum Ltd. (Ireland).

Major Types of Vascular Closure Devices Market covered are:

Interventional Cardiology, Interventional Radiology/Vascular Surgery

Vascular Closure Devices Market, by Type

  • Passive Approximators
  • Collagen Plugs
  • Sealant- or Gel-based Devices
  • Compression-assist Devices
  • Active Approximators
  • Suture-based Devices
  • Clip-based Devices
  • External Hemostatic Devices

Geographic analysis reveals that the North American segment is expected to account for the largest share of the market in 2017, owing to the increasing prevalence of cardiovascular diseases in the U.S., growing trend of one-day surgery for vascular procedures, and the increasing number of research and clinical trials for vascular closure devices.

All Posts
×

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OKSubscriptions powered by Strikingly